Sensei Biotherapeutics, Inc. announced the appointment of Stephanie Krebs, MS, MBA, as Chief Business Officer. Ms. Krebs joins Sensei from SNIPR Biome, a clinical-stage biotechnology company where, as Chief Business Officer, she was responsible for defining the companys growth and partnering activities, including value creation through collaborations with large pharmaceutical and biotech partners. Prior to this, she held business and corporate development roles of increasing responsibility in a number of companies, including Valo Health, bluebird bio, HotSpot Therapeutics and Swedish Orphan Biovitrum (Sobi) AB.

Ms. Krebs also spent 10 years at Biogen, where she initially supported commercial activities before moving into business development and focused on generating strategic partnerships for the companys neurology and immunology pipelines. Ms. Krebs holds an MS in biotechnology from Johns Hopkins University and an MBA from the University of Rochester.